To evaluate the role of clock control genes in the progression, to find reliable biological targets, and to optimize the diagnosis, prognosis, and treatment of pan-RCC over time, we analyzed the altered expression, mutation, and methylation status of rhythmic genes in patients with RCC. The gene discussed is CLOCK; the disease is renal cell carcinoma.